GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21WAF1 and p27Kip1 proteins

Blood

Volumn 100, Issue 10, 2002, Pages 3512-3520

  Ezoe, Sachiko ^a,b,c,d   Matsumura, Itaru ^a,b,c,d   Nakata, Soichi ^a,b,c,d   Gale, Karin ^a,b,c,d   Ishihara, Katsuhiko ^a,b,c,d   Minegishi, Naoko ^a,b,c,d   Machii, Takashi ^a,b,c,d   Kitamura, Toshio ^a,b,c,d   Yamamoto, Masayuki ^a,b,c,d   Enver, Tariq ^a,b,c,d   Kanakura, Yuzuru ^a,b,c,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTRADIOL; ESTROGEN RECEPTOR; INTERLEUKIN 3; LIGASE; MESSENGER RNA; PROTEASOME; PROTEIN; PROTEIN CUL1; PROTEIN P21; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR GATA 2; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH REGULATION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0037111762     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1177     Document Type: Article

References (53)

1. Weiss MJ, Orkin SH. GATA transcription factors: Key regulators of hematopoiesis. Exp Hematol. 1995;23:99-107.
2. Martin DI, Orkin SH. Transcriptional activation and DNA-binding by the erythroid factor GF-1. Genes Dev. 1990;4:1886-1898.
3. Yang H-Y, Evans-T. Distinct roles for the two cGATA-1 finger domains. Mol Cell Biol. 1992;12:4562-4570.
4. Evans T, Felsenfeld G. The erythroid-specific transcription factor eryf1: A new finger protein. Cell. 1989;58:877-885.
5. Tsai SF, Martin DIK, Zon LI, D'Andrea AD, Wong CG, Orkin SH. Cloning of cDNA for the major DNA binding protein of the erythroid lineage through expression in mammalian cells. Nature. 1989;339:446-451.
6. Martin DI, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990;344:444-447.
7. Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 1990.344:447-449.
8. Penvy L, Simon MC, Robertson E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349:257-260.
9. Weiss MJ, Orkin SH. Novel insights into erythroid differentiation revealed through differentiation of GATA-1-embryonic stem cells. Genes Dev. 1994;8:1184-1197.
10. Weiss MJ, Orkin SH. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A. 1995;92:9623-9627.
11. Schivdasani RA, Fujiwara Y, McDevitt M, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965-3973.
12. Pandolfi PP, Roth ME, Karis A, et al. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet. 1995;11:40-44.
13. Ting C-N., Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature. 1996;384:474-478.
14. Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A. 1995;92:4601-4605.
15. Dorfman DM, Wilson DB, Bruns GAP, Orkin SH. Human transcription factor GATA-2: Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem. 1992;267:1279-1285.
16. Jippo T, Mizuno H, Xu Z, Nomura S, Yamamoto M, Kitamura Y. Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: Demonstration by in situ hybridization. Blood. 1996;87:993-998.
17. Leonard M, Brice M, Engel JD, Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood. 1993;82:1071-1079.
18. Visvader JE, Adams JM. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood. 1993;82:1493-1501.
19. Tsai F-Y, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221-226.
20. Tsai F-Y, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89:3636-3643.
21. Persons DA, Allay JA, Allay ER, et al. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. 1999;93:488-499.
22. Heyworth C, Gale K, Dexter M, May G, Enver T. A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of selfrenewal. Genes Dev. 1999;13:1847-1860.
23. Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1512.
24. Hochstrasser M. Ubiquitin, proteasome, and the regulation of intracellular protein degradation. Curr Opin Cell Biol. 1995;7:215-223.
25. Varshavsky A. The ubiquitin system. Trends Biochem Sci. 1997;22:383-387.
26. Metcalf, D. Stem cells, pre-progenitor cells and lineage-committed cells: Are our dogmas correct? Ann N Y Acad Sci. 1999;872:289-303.
27. Morrison SJ, Uchida N, Weissman II. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35-71.
28. cip1/waf1. Science. 2000;287:1804-1808.
29. Matsumura I, Kitamura T, Wakao H, et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 1999;18:1367-1377.
30. Matsumura I, Kanakura Y, Kato T, et al. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood. 1995;86:703-709.
31. Tanaka H, Matsumura I, Nakajima K, et al. GATA-1 blocks IL-6-Induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1. Blood. 2000;95:1264-1273.
32. Matsumura I, Tanaka H, Kawasaki A, et al. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line. J Biol Chem. 2000;275:5553-5559.
33. Morita S, Kijima T, Kitamura T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:41063-1066.
34. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27, Nat Cell Biol. 1999;1:193-199.
35. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Curr Biol. 1999;9:661-664.
36. CIP1/WAF1 and cyclin D proteins. Proc Natl Acad Sci U S A. 1998;95:11324-11329.
37. Hermeking H, Rago C, Schuhmacher M, et al. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A. 2000;97:2229-2234.
38. O'Hagan RC, Ohh M, David G, et al. Myc-enhanced expression of Cull promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 2000;14:2185-2191.
39. Ema H, Takano H, Sudo K, Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J Exp Med. 2000;192:1281-1288.
40. Blobel GA, Nakajima T, Eckner R, Montminy M, Orkin SH. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci U S A. 1998;95:2061-2066.
41. Matsumura I, Kawasaki A, Tanaka H, et al. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines. Blood. 2000;96:2440-2450.
42. Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol. 1995;15:2437-2447.
43. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: Functional antagonism in erythroid cells. Genes Dev. 1999;13:1398-1411.
44. Tsuzuki S, Towatarl M, Saito H, Enver T. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. Mol Cell Biol. 2000;20:6276-6286.
45. Wadman IA, Osada H, Grutz CG, et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 1997;16:3145-3157.
46. Zhang P, Behre G, Pan J, et al. Negative crosstalk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci U S A. 1999;96:8705-8710.
47. Motohashi H, Katsuoka F, Shavit JA, Engel JD, Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell. 2000;103:865-875.
48. Tarumoto T, Imagawa S, Ohmine K, et al. NGmonomethyl-L-arginine inhibits erythropoletin gene expression by stimulating GATA-2. Blood. 2000;96:1716-1722.
49. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science. 2000;290:134-138.
50. Kerkhoff E, Houben R, Loffler S, Troppmair J, Lee JE, Rapp UR. Regulation of c-myc expression by Ras/Raf signalling. Oncogene. 1998;16:211-216.
51. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med. 1999;189:63-73.
52. kip1. Nat Med. 2000;6:1235-1240.
53. Kitajima K, Masuhara M, Era T et al. GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO J. 2002;21:3060-3069.